Bellus Health Stock Target Price and Analyst Consensus

BLU
 Stock
  

USD 8.32  0.22  2.72%   

The current analyst and expert consensus on Bellus Health is Buy, with 0 strong sell and 7 strong buy opinions. The current projected Bellus Health target price consensus is 13.69 with 8 analyst opinions. The most common way Bellus Health analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Bellus Health executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Bellus Health. We strongly encourage you to use your own analysis of Bellus Health to validate this buy or sell advice. Bellus Health buy-or-sell recommendation module provides average expert sentiment on the projected Bellus Health target price to derive its highest and lowest estimates based on projected price volatility of 4.3. Continue to Macroaxis Advice on Bellus Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
Gross Profit is likely to gain to about 16.4 K in 2022, whereas Profit Margin is likely to drop (11.03)  in 2022. Bellus Health Total Assets are comparatively stable at the moment as compared to the past year. Bellus Health reported Total Assets of 309.6 Million in 2021. Current Assets is likely to gain to about 278.6 M in 2022, whereas Investments are likely to drop slightly above 79.3 M in 2022.

Bellus Health Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bellus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bellus target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions8
Lowered Outlook0
Raized Outlook0
Buy
Most Bellus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bellus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bellus Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Bellus Health Target Price Projection

Bellus Health's current and average target prices are 8.32 and 13.69, respectively. The current price of Bellus Health is the price at which Bellus Health is currently trading. On the other hand, Bellus Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Bellus Health Market Quote on 27th of June 2022

Low Price8.1Odds
High Price8.4Odds

8.32

Target Price

Analyst Consensus On Bellus Health Target Price

Low Estimate7.5Odds
High Estimate20.0Odds
Number of Analysts8
Standard Deviation4.3

13.687

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Bellus Health and the information provided on this page.

Bellus Health Analyst Ratings

Bellus Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Bellus Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Bellus Health's financials, market performance, and future outlook by experienced professionals. Bellus Health's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Bellus Health Target Price Projections

Bellus Health's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Bellus Health and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Bellus depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Bellus Health including analysis of its current option contracts.
Bellus Health's latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 117.69 with a put-to-call open interest ratio of 0.96 over 12 outstanding agreements suggesting . The current put volume is at 18, with calls trading at the volume of 28. This yields a 0.64 put-to-call volume ratio. The Bellus Health option chain provides detailed quote and price information for the current Bellus Health option contracts. It shows all of Bellus Health's listed puts, calls, expiration dates, strike prices, and other pricing information.
Bellus Health's stock options are financial instruments that give investors the right to buy or sell shares of Bellus Health common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Bellus stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Bellus Health's stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Bellus Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Bellus Health In The Money Call Balance

When Bellus Health's strike price is surpassing the current stock price, the option contract against Bellus Health stock is said to be in the money. When it comes to buying Bellus Health's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Bellus Health are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Bellus Current Options Market Mood

Bellus Health's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bellus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Bellus Health's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Bellus Health's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Bellus Health's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Bellus Health Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bellus Health is a key component of Bellus Health valuation and have some predictive power on the future returns of a Bellus Health.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bellus Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bellus Health in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
3.668.4513.24
Details
Intrinsic
Valuation
LowReal ValueHigh
4.809.5914.38
Details
Naive
Forecast
LowNext ValueHigh
3.528.3113.10
Details
Earnings
Estimates (5)
LowProjected EPSHigh
-1.06-0.92-0.6
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bellus Health. Your research has to be compared to or analyzed against Bellus Health's peers to derive any actionable benefits. When done correctly, Bellus Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bellus Health.

Additional Bellus Health Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bellus Health is a key component of Bellus Health valuation and have some predictive power on the future returns of a Bellus Health.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bellus Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bellus Health in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
3.668.4513.24
Details
Intrinsic
Valuation
LowReal ValueHigh
4.809.5914.38
Details
Naive
Forecast
LowNext ValueHigh
3.528.3113.10
Details
Earnings
Estimates (5)
LowProjected EPSHigh
-1.06-0.92-0.6
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bellus Health. Your research has to be compared to or analyzed against Bellus Health's peers to derive any actionable benefits. When done correctly, Bellus Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bellus Health.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Top FinTech
Invested over 90 shares
Food Products
Invested over 90 shares
Baby Boomer Prospects
Invested over 90 shares
Robots And Drones
Invested over 90 shares
Continue to Macroaxis Advice on Bellus Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The data published in Bellus Health's official financial statements usually reflect Bellus Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bellus Health. For example, before you start analyzing numbers published by Bellus accountants, it's critical to develop an understanding of what Bellus Health's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Bellus Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bellus Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bellus Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bellus Health. Please utilize our Beneish M Score to check the likelihood of Bellus Health's management to manipulate its earnings.